Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

References

• Cancer today, (n.d.). http://gco.iarc.fr/today/home (accessed February 13, 2018).
   Google Scholar
• Broderick P, Chubb D, Johnson DC, et al. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat Genet. 2012;44:58–61.
   Web of Science ®Google Scholar
• Chubb D, Weinhold N, Broderick P, et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet. 2013;45:1221–1225.
   PubMed Web of Science ®Google Scholar
• Weinhold N, Johnson DC, Chubb D, et al. The CCND1 c.870G > A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. Nat Genet. 2013;45:522–525.
   PubMed Web of Science ®Google Scholar
• Swaminathan B, Thorleifsson G, Jöud M, et al. Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma. Nat Commun. 2015;6:7213.
   PubMed Web of Science ®Google Scholar
• Mitchell JS, Li N, Weinhold N, et al. Genome-wide association study identifies multiple susceptibility loci for multiple myeloma. Nat Commun. 2016;7:12050.
   PubMed Web of Science ®Google Scholar
• Campa D, Martino A, Varkonyi J, et al. Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. Int J Cancer. 2015;136:E351–E358.
   PubMed Web of Science ®Google Scholar
• Macauda A, Calvetti D, Maccari G, et al. Identification of miRSNPs associated with the risk of multiple myeloma. Int J Cancer. 2017;140:526–534.
   PubMed Web of Science ®Google Scholar
• Ríos-Tamayo R, Lupiañez CB, Campa D, et al. A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis. Oncotarget. 2016;7:59029–59048.
   PubMedGoogle Scholar
• Ziv E, Dean E, Hu D, et al. Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Na Commun. 2015;6:7539.
   PubMed Web of Science ®Google Scholar
• Johnson DC, Weinhold N, Mitchell JS, et al. Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma. Nat Commun. 2016;7:10290.
   PubMed Web of Science ®Google Scholar
• Mitchell JS, Johnson DC, Litchfield K, et al. Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma. Sci Rep. 2015;5:12473.
   PubMed Web of Science ®Google Scholar
• Kumar SK, Rajkumar V, Kyle RA, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046.
   PubMed Web of Science ®Google Scholar
• Gellert M. Recent advances in understanding V(D)J recombination. Adv Immunol. 1997;64:39.
   PubMed Web of Science ®Google Scholar
• Stavnezer J, Guikema JEJ, Schrader CE. Mechanism and regulation of class switch recombination. Annu Rev Immunol. 2008;26:261–292.
   PubMed Web of Science ®Google Scholar
• Hwang JK, Alt FW, Yeap L-S. Related mechanisms of antibody somatic hypermutation and class switch recombination. Microbiol Spectr. 2015;3:2014.
   Web of Science ®Google Scholar
• Xu Z, Fulop Z, Zhong Y, et al. DNA lesions and repair in immunoglobulin class switch recombination and somatic hypermutation. Ann N Y Acad Sci. 2005;1050:146–162.
   PubMed Web of Science ®Google Scholar
• Methot SP, Di Noia JM. Molecular mechanisms of somatic hypermutation and class switch recombination. Adv Immunol. 2017;133:37–87.
   PubMed Web of Science ®Google Scholar
• Roddam PL, Rollinson S, O’Driscoll M, et al. Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination. J Med Genet. 2002;39:900–905.
   PubMed Web of Science ®Google Scholar
• Hayden PJ, Tewari P, Morris DW, et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Hum Mol Genet. 2007;16:3117–3127.
   PubMed Web of Science ®Google Scholar
• Cifci S, Yilmaz M, Pehlivan M, et al. DNA repair genes polymorphisms in multiple myeloma: no association with XRCC1 (Arg399Gln) polymorphism, but the XRCC4 (VNTR in intron 3 and G-1394T) and XPD (Lys751Gln) polymorphisms is associated with the disease in Turkish patients. Hemato Amst Neth. 2011;16:361–367.
   PubMed Web of Science ®Google Scholar
• Velangi MR, Matheson EC, Morgan GJ, et al. DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma. Carcinogenesis. 2004;25:1795–1803.
   PubMed Web of Science ®Google Scholar
• Cibeira MT, de Larrea CF, Navarro A, et al. Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide. Leuk Res. 2011;35:1178–1183.
   PubMed Web of Science ®Google Scholar
• Dumontet C, Landi S, Reiman T, et al. Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan. Bone Marrow Transplant. 2010;45:1316–1324.
   PubMed Web of Science ®Google Scholar
• Martino A, Sainz J, Buda G, et al. Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). Int J Oncol. 2012;40:625–638.
   PubMed Web of Science ®Google Scholar
• Löw M, Stegmaier C, Ziegler H, ESTHER study, et al. [Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population (ESTHER study)]. Dtsch Med Wochenschr. 2004;129:2643–2647.
   PubMed Web of Science ®Google Scholar
• Gao X, Starmer J, Martin ER. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol. 2008;32:361–369.
   PubMed Web of Science ®Google Scholar
• Boyle AP, Hong EL, Hariharan M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22:1790–1797.
   PubMed Web of Science ®Google Scholar
• Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:D930–D934.
   PubMed Web of Science ®Google Scholar
• Battle A, Brown CD, Engelhardt BE, GTEx Consortium, Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group, Statistical Methods groups—Analysis Working Group, Enhancing GTEx (eGTEx) groups, NIH Common Fund, NIH/NCI, NIH/NHGRI, NIH/NIMH, NIH/NIDA, Biospecimen Collection Source Site—NDRI, Biospecimen Collection Source Site—RPCI, Biospecimen Core Resource—VARI, Brain Bank Repository—University of Miami Brain Endowment Bank, Leidos Biomedical—Project Management, ELSI Study, Genome Browser Data Integration &Visualization—EBI, Genome Browser Data Integration &Visualization—UCSC Genomics Institute, University of California Santa Cruz, Lead analysts:, Laboratory, Data Analysis &Coordinating Center (LDACC):, NIH program management:, Biospecimen collection:, Pathology:, eQTL manuscript working group, et al. Genetic effects on gene expression across human tissues. Nature. 2017;550:204–213.
   PubMed Web of Science ®Google Scholar
• Fenton J. a L, Pratt G, Rawstron AC, et al. Isotype class switching and the pathogenesis of multiple myeloma. Hematol Oncol. 2002;20:75–85.
   PubMed Web of Science ®Google Scholar
• Chesi M, Robbiani DF, Sebag M, et al. AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. Cancer Cell. 2008;13:167–180.
   PubMed Web of Science ®Google Scholar